Figure 1.
Selection of studies for the meta-analysis of IOUS associated negative margins of breast cancer.
Table 1.
Characteristics of eligible studies about the efficacy of IOUS on margin status included in the study.
Table 2.
Summary ORs or RRs and 95% CI of IOUS associated negative margins.
Figure 2.
Impact of IOUS on rates of negative margins of all breast cancers (prospective studies).
Forest plot for meta-analysis of prospective studies: rate of negative margins of all breast cancers (including non-palpable and palpable breast cancers) in IOUS group compared with that in control group without IOUS. The width of the horizontal line represents the 95% CI of the individual study, and the square proportional represents the weight of each study. The diamond represents the pooled RR and 95% CI.
Figure 3.
Impact of IOUS on rates of negative margins of all breast cancers (retrospective studies).
Forest plot for meta-analysis of retrospective studies: rate of negative margins of breast cancers (including non-palpable and palpable breast cancers) in IOUS group compared with that in control group without IOUS. The width of the horizontal line represents the 95% CI of the individual study, and the square proportional represents the weight of each study. The diamond represents the pooled OR and 95% CI.
Figure 4.
Impact of IOUS on rates of negative margins of non-palpable breast cancers (prospective studies).
Forest plot for meta-analysis of prospective studies: rate of negative margins of non-palpable breast cancers in IOUS group compared with that in GWL group. The width of the horizontal line represents the 95% CI of the individual study, and the square proportional represents the weight of each study. The diamond represents the pooled RR and 95% CI.
Figure 5.
Impact of IOUS on rates of negative margins of non-palpable breast cancers (retrospective studies).
Forest plot for meta-analysis of retrospective studies: rate of negative margins of non-palpable breast cancers in IOUS group compared with that in GWL group. The width of the horizontal line represents the 95% CI of the individual study, and the square proportional represents the weight of each study. The diamond represents the pooled OR and 95% CI.
Figure 6.
Impact of IOUS on rates of negative margins of palpable breast cancers.
Forest plot for meta-analysis: rate of negative margins of palpable breast cancers in IOUS group compared with that in control group without IOUS. The width of the horizontal line represents the 95% CI of the individual study, and the square proportional represents the weight of each study. The diamond represents the pooled RR or OR and 95% CI.